期刊文献+

PP方案诱导化疗联合放疗治疗晚期鼻咽癌临床观察 被引量:3

Clinical Observation of Program of PP Inducement Chemotherapy Associatd with Radiotherapy in the Treatment of Patients with Advanced Nasopharyngeal Carcinoma
暂未订购
导出
摘要 目的 观察P(Paclitaxel ,PTX)P(DDP)方案诱导化疗联合放疗对晚期鼻咽癌的治疗效果。方法 观察组 40例鼻咽癌患者给予PP方案 (PTX 15 0mg/m2 d1,DDP 10 0mg/m2 d2 ) ,化疗 2~ 3周期后常规放疗 (鼻咽 66~ 74Gy ,颈部淋巴结 62~ 70Gy ,颈部淋巴结预防量44~ 5 0Gy) ,对照组 46例给予常规放疗。结果 观察组总有效率为 72 5 % ,对照组为 5 0 0 % ,有显著差异 (P <0 0 5 ) ;3年生存率分别为 5 7 9% ,43 5 % (P <0 0 5 ) ;3年局部控制率分别为 71 1% ,5 6 5 % (P <0 0 5 ) ;3年远处转移率分别为 2 1 1% ,3 9 1% (P <0 0 5 )。结论 PP方案可用于鼻咽癌诱导化疗 ,增加放疗敏感性 ,提高 3年生存率及局部控制率 ,降低了远处转移率。 Objective To study the influence of program PP inducement chemotherapy associated with radiotherapy in the treatment of advanced nasopharyngeal carcinoma patients.Methods The testing group was treated with Paclitaxel+DDP(PTX 150 mg/m 2 d 1,DDP 100 mg/m 2 d 2)for 2~3 courses then followed by normal radiotherapy(primary tumor with 66~74Gy,involved areas of the neck with 62~70Gy,the univolved areas with 44~50Gy),the control group was given the same radiotherapy alone.Result The testing group achieved all response rate 72.5%,while the control group only 50.5%,There was significant difference between the two groups (P<0.05),The 3-year survival rates of the two groups were 57.9%、43.5% (P<0.05),The 3-year control rates and distant metastasis rates of the two groups were 71.1%、56.5% and 21.1%、39.1%(P<0.05).Conclusions PTX+DDP could be used in the inducement chemotherapy of nasopharyngeal carcinoma.
作者 李高峰
出处 《河南肿瘤学杂志》 2004年第5期338-339,共2页 Henan Journal of Oncology
关键词 紫杉醇 顺铂 鼻咽肿瘤 诱导化疗 放射治疗 Paclitaxel DDP nasopharyngeal carcinoma chemotherapy radiotherapy
  • 相关文献

参考文献3

二级参考文献14

共引文献30

同被引文献56

引证文献3

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部